Thursday, February 22, 2018

ImmunoCellular Therapeutics Seeks Buyer, Hires Investment Banker

Los Angeles-based biotechnology developer ImmunoCellular Therapeutics said this morning that it has launched a "review of strategic alternatives", and has hired an investment banking firm, Ladenburg Thalmann & Co. Inc., as a strategic financial advisor. According to the company, Ladenberg will assist in review of the company's business and assets and exploration of strategic opportunities for enhancing stockholder value, including the potential sale or merger of the company. ImmunoCellular Therapeutics is developing immunotherapies based on stem cells, for the treatment of cancer, and is listed on the NYSE American as IMUC.

---